01—Abstract
Summary
Summary of the 8-K filed November 3, 2025. Cited figures are marked; the original filing is the authoritative source.
Kenvue Inc. reported third-quarter 2025 results for the fiscal quarter ended September 28, 2025.
Net sales were $3,764 milliona, down 3.5% from $3,899 million a year earlier. The decline reflected a 4.4% decrease in Organic sales, partially offset by a 1.0% foreign currency benefit. Management attributed the weakness to a 4.0% volume decrease, 0.4% unfavorable value realization from planned strategic price investments, lower seasonal incidences affecting Self Care, trade inventory reductions at some customers, and shipment timing changes in China.
GAAP diluted earnings per share were $0.21b, versus $0.20 a year earlier, and Adjusted diluted earnings per share were $0.28 in both periods. Gross profit margin rose to 59.1% from 58.5%, while operating income margin was 16.7% versus 16.8%. Kenvue affirmed its full-year 2025 outlook.
It expects net sales and Organic sales to decline by low single digits with approximately neutral foreign currency impact, an year-over-year decline in Adjusted operating income margin, and Adjusted diluted EPS of $1.00 to $1.05c. The company also disclosed a definitive merger agreement under which Kimberly-Clark will acquire all outstanding Kenvue common stock in a cash and stock transaction, as described in a separate release. As a result, Kenvue will not host an earnings conference call.
Kirk Perry was named permanent Chief Executive Officer, and several leadership changes were announced, including a new Chief Digital and Marketing Officer effective November 17, 2025 and the elimination of the Chief Growth Officer role. Balance sheet and cash flow metrics were stable. Net cash flows from operating activities were $1.3 billiond for the nine months ended September 28, 2025, compared with $1.0 billion a year earlier, and free cash flow was $1.0 billion versus $0.7 billion.
Total debt was $9.0 billion and cash and cash equivalents were $1.1 billion, resulting in net debt of $7.8 billion as of September 28, 2025. The prepared remarks also addressed public commentary about Tylenol and acetaminophen, noting that U.S. Children's Tylenol represents approximately 1% of Net sales.
02—Key points
Key Highlights
- Q3 2025 Net sales of $3,764 million, down 3.5% from $3,899 million, with Organic sales down 4.4% and a 1.0% foreign currency benefit.
- GAAP diluted EPS of $0.21 vs $0.20 a year earlier; Adjusted diluted EPS of $0.28 in both periods.
- Gross profit margin of 59.1% vs 58.5%; Adjusted gross profit margin of 61.2% vs 60.7%; Adjusted operating income margin of 21.5% vs 22.1%.
- FY 2025 outlook affirmed: Adjusted diluted EPS of $1.00 to $1.05, net and Organic sales down low single digits, and Adjusted operating margin expected to decline.
- Definitive merger agreement with Kimberly-Clark under which Kimberly-Clark will acquire all outstanding Kenvue common stock in a cash and stock transaction; no earnings webcast will be held.
- Kirk Perry named permanent CEO; Carlos De Jesus appointed Group President, North America; Jonathan Halvorson to join as Chief Digital and Marketing Officer effective November 17, 2025; Chief Growth Officer role eliminated.
- Nine-month free cash flow of $1.0 billion vs $0.7 billion; net debt of $7.8 billion at September 28, 2025.
03—Questions
Frequently Asked Questions
Why did Kenvue's net sales decline in the third quarter?
Net sales decreased 3.5% to $3,764 million, reflecting a 4.4% Organic sales decline partially offset by a 1.0% foreign currency benefit. Management cited a 4.0% volume decrease, 0.4% unfavorable value realization from planned strategic price investments, lower seasonal incidences affecting Self Care, trade inventory reductions at some customers, and changes in shipment timing in China.
What is the status of Kenvue's 2025 guidance?
Kenvue affirmed its full-year 2025 outlook. It expects net sales and Organic sales to decline by low single digits with approximately neutral foreign currency impact, a year-over-year decline in Adjusted operating income margin, and Adjusted diluted EPS in the range of $1.00 to $1.05. The outlook assumes current foreign exchange rates and tariffs in place as of October 31, 2025.
What does the Kimberly-Clark transaction mean for Kenvue shareholders?
Kenvue announced a definitive merger agreement under which Kimberly-Clark will acquire all outstanding Kenvue common stock in a cash and stock transaction, as described in a separate release. Kenvue will no longer host its planned quarterly earnings conference call, and prepared remarks were posted to its website instead. The filing lists the possibility that the transaction is not consummated among its risk factors.
What leadership changes were announced?
The Board named Kirk Perry Chief Executive Officer on a permanent basis, effective immediately; he had served as Interim CEO since July 14, 2025. Carlos De Jesus was appointed Group President, North America, effective November 3, 2025, succeeding Jan Meurer, who will depart after a transition period. Jonathan Halvorson will join as Chief Digital and Marketing Officer effective November 17, 2025. The Chief Growth Officer role is being eliminated, and Charmaine England will leave the Company after a transition period.
How strong were Kenvue's cash flow and balance sheet metrics?
For the nine months ended September 28, 2025, net cash flows from operating activities were $1.3 billion versus $1.0 billion a year earlier, and free cash flow was $1.0 billion versus $0.7 billion. As of September 28, 2025, cash and cash equivalents were $1.1 billion, total debt was $9.0 billion, and net debt was $7.8 billion.
04—Continue